This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Jun;37(6):1326.

doi: 10.1002/mds.29038. Epub 2022 Apr 28.

Risk Disclosure in Prodromal Parkinson's Disease

James L Karagianis¹

Affiliations

PMID: 35481903
DOI: 10.1002/mds.29038

Comment

Risk Disclosure in Prodromal Parkinson's Disease

James L Karagianis. Mov Disord. 2022 Jun.

. 2022 Jun;37(6):1326.

doi: 10.1002/mds.29038. Epub 2022 Apr 28.

Author

James L Karagianis¹

Affiliation

¹ Clinical Associate Professor of Psychiatry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.

PMID: 35481903
DOI: 10.1002/mds.29038

No abstract available

PubMed Disclaimer

Comment in

Reply to: "Risk Disclosure in Prodromal Parkinson's Disease".
Schaeffer E, Toedt I, Köhler S, Rogge A, Berg D. Schaeffer E, et al. Mov Disord. 2022 Jun;37(6):1327. doi: 10.1002/mds.29036. Mov Disord. 2022. PMID: 35707826 No abstract available.

Comment on

Risk Disclosure in Prodromal Parkinson's Disease.
Schaeffer E, Toedt I, Köhler S, Rogge A, Berg D. Schaeffer E, et al. Mov Disord. 2021 Dec;36(12):2833-2839. doi: 10.1002/mds.28723. Epub 2021 Aug 5. Mov Disord. 2021. PMID: 34351002 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information